| Constellation Technologies Limited (CT1) ORDINARY FULLY PAID |
Information Technology |
$4 |
Appendix 4G
|
29 Aug 2025 9:35AM |
$0.002 |
$0.003 |
risen by
50%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$12 |
Appendix 4E Preliminary Final Report
|
29 Aug 2025 9:35AM |
$0.069 |
$0.036 |
fallen by
47.83%
|
|
IMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Comprehensive loss after tax of $5,253,209 for the year ended 30 June 2025.
- Revenue from contracts with customers increased to $7,287,002.
- Net assets decreased to $8,031,833 from $12,709,444 in the previous year.
- Significant decrease in cash and cash equivalents to $2,830,526.
- Share capital increased to $88,872,756 due to share issues.
- Continued issuance of options and performance rights to key personnel.
- Post-year-end capital raising through At The Market facility in July 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$12 |
Appendix 4E Preliminary Final Report
|
29 Aug 2025 9:35AM |
$0.069 |
$0.036 |
fallen by
47.83%
|
|
IMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 48.6% to $7,287,002.
- Loss after tax reduced by 24.3% to $5,253,209.
- Research and development expenses of $3,597,296.
- Cash position decreased to $2,830,526.
- No dividends paid or declared for the current or previous financial year.
- Continued strong sales of Travelan® in Australia and North America.
- 23.6% interest in Ateria Health Limited.
- Detailed audited financial statements expected by 30 September 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flexiroam Limited (FRX) ORDINARY FULLY PAID |
Communication Services |
$26 |
Corporate Governance Statement and Appendix 4G
|
29 Aug 2025 9:34AM |
$0.006 |
$0.017 |
risen by
183.33%
|
|
| Gale Pacific Limited (GAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$21 |
FY 25 Appendix 4G and Corporate Governance Statement
|
29 Aug 2025 9:34AM |
$0.098 |
$0.075 |
fallen by
23.47%
|
|
| Finexia Financial Group Limited (FNX) ORDINARY FULLY PAID |
Financials |
$11 |
Suspension from Quotation
|
29 Aug 2025 9:34AM |
$0.145 |
$0.180 |
risen by
24.14%
|
|
FNX - Price-sensitive ASX Announcement
Full Release
Key Points
- The securities of Finexia Financial Group Limited will be suspended from quotation immediately.
- The suspension is under Listing Rule 17.3.4.
- Suspension is pending the release of an announcement related to media speculation and a potential material acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$16 |
2025 Appendix 4G and Corporate Governance Statement
|
29 Aug 2025 9:34AM |
$0.018 |
$0.018 |
fallen by
0%
|
|
| Gale Pacific Limited (GAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$21 |
FY25 Annual Report
|
29 Aug 2025 9:34AM |
$0.098 |
$0.075 |
fallen by
23.47%
|
|
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$16 |
FY25 Results Presentation
|
29 Aug 2025 9:34AM |
$0.018 |
$0.018 |
fallen by
0%
|
|
| Constellation Technologies Limited (CT1) ORDINARY FULLY PAID |
Information Technology |
$4 |
2025 Corporate Governance Statement
|
29 Aug 2025 9:33AM |
$0.002 |
$0.003 |
risen by
50%
|
|
| EPX Limited (EPX) ORDINARY FULLY PAID |
Information Technology |
$15 |
2025 Results Announcement
|
29 Aug 2025 9:32AM |
$0.029 |
$0.170 |
risen by
486.21%
|
|
EPX - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory revenue increased by 17% to $15.3 million.
- Recurring revenue grew by 23% to account for 98% of total revenue.
- Underlying EBITDA loss decreased by 56% to $0.6 million.
- Net loss after tax was $5.75 million.
- Operational cash flow was positive at $1.4 million.
- Expenses increased due to strategic investments and acquisition costs.
- EPX launched the EDGE Industrial platform.
- Focus on expanding into commercial, hotel, and retail office markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EPX Limited (EPX) ORDINARY FULLY PAID |
Information Technology |
$15 |
2025 Results Announcement
|
29 Aug 2025 9:32AM |
$0.029 |
$0.170 |
risen by
486.21%
|
|
EPX - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory revenue increased by 17% to $15.3 million.
- Recurring revenue grew by 23%, representing 98% of total revenue.
- Net loss after tax increased by 15% to $5.75 million.
- Underlying EBITDA loss reduced by 56% to $0.6 million.
- Significant operational cash inflow of $1.4 million.
- Acquisition of Coda Cloud technology and launch of Edge Industrial.
- Rebranding to 'epx'.
- Focus on growth in commercial, hotel, and retail office verticals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EPX Limited (EPX) ORDINARY FULLY PAID |
Information Technology |
$15 |
2025 Appendix 4G and Corporate Governance Statement
|
29 Aug 2025 9:32AM |
$0.029 |
$0.170 |
risen by
486.21%
|
|
| Golden Horse Minerals Limited (GHM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$102 |
Management Discussion & Analysis June 2025
|
29 Aug 2025 9:31AM |
$0.475 |
$0.470 |
fallen by
1.05%
|
|
| Caprice Resources Limited (CRS) ORDINARY FULLY PAID |
Materials |
$73 |
Application for quotation of securities - CRS
|
29 Aug 2025 9:31AM |
$0.088 |
$0.084 |
fallen by
4.55%
|
|
| Constellation Technologies Limited (CT1) ORDINARY FULLY PAID |
Information Technology |
$4 |
Appendix 4E and Annual Report
|
29 Aug 2025 9:31AM |
$0.002 |
$0.003 |
risen by
50%
|
|
CT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Constellation Technologies Limited reported a net profit of $9,521 for the financial year ending 30 June 2025, compared to a net loss of $121,666 in the previous year.
- Revenue for the year increased to $1,807,330 from $1,346,072, marking a 34.27% growth.
- There was no dividend declared or distributed during the financial year.
- The company's net tangible assets per security decreased from 0.04 cents per share to 0.02 cents per share.
- The annual report includes comprehensive financial statements, a director's declaration, and an independent auditor's report.
- The financial statements comply with the Australian Accounting Standards and the Corporations Act 2001.
- The report includes details about key management personnel and their remuneration.
- The company is primarily exposed to foreign exchange risks due to transactions in Chinese yuan and Indian rupee against the Australian dollar.
- Significant financial risk management practices include credit risk monitoring and procedures for approving credit limits.
- The company issued 32,000,000 performance rights as part of its employee share option plan.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Perpetual Ethical SRI Fund (Managed Fund) (GIVE) |
Financials |
$13 |
Monthly Investment Update - July 2025
|
29 Aug 2025 9:31AM |
$3.210 |
$2.890 |
fallen by
9.97%
|
|
| Barrow Hanley Global Share Fund (Managed Fund) (GLOB) |
Financials |
$481 |
Monthly Investment Update - July 2025
|
29 Aug 2025 9:31AM |
$4.800 |
$4.580 |
fallen by
4.58%
|
|
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$16 |
2025 Appendix 4E and Annual Report
|
29 Aug 2025 9:30AM |
$0.018 |
$0.018 |
fallen by
0%
|
|
AT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 7% to AUD 3,792,359.
- Net loss improved by 28% to AUD 4,895,468.
- No dividends were declared during the financial period.
- Basic earnings per share were negative at (0.768) AUD cents.
- Total assets were AUD 9,277,326 with net assets at AUD 6,975,816.
- Significant director changes with appointments and resignations noted.
- Annual General Meeting scheduled for 31 October 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$16 |
2025 Appendix 4E and Annual Report
|
29 Aug 2025 9:30AM |
$0.018 |
$0.018 |
fallen by
0%
|
|
AT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Atomo Diagnostics Limited reported a 7% decrease in revenue from ordinary activities, amounting to AUD 3,792,359 for the period ended 30 June 2025.
- The loss from ordinary activities after tax attributable to owners was down 27% to AUD 4,970,934.
- Basic and diluted earnings per share were both reported at negative 0.768 AUD cents.
- No dividends were paid, recommended, or declared during the financial period.
- Net tangible asset per ordinary security decreased from 1.25 to 0.72 AUD.
- The financial statements were audited with an unmodified opinion issued.
- The company held an Annual General Meeting on 31 October 2025.
- Atomo Diagnostics Limited's principal activities include the development and sale of medical devices.
- Operating cash flows were negatively impacted, with receipts from customers totaling AUD 5,137,858 in contrast to payments of AUD 8,982,195.
- The company reported net assets of AUD 6,975,816 as of 30 June 2025, down from AUD 10,084,619 the previous year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$81 |
Appendix 4E & 2025 Full Year Statutory Accounts
|
29 Aug 2025 9:30AM |
$0.245 |
$0.055 |
fallen by
77.55%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue and income of $7.84 million
- Loss before tax of $42.72 million
- Significant expenses in R&D, employee benefits, and intellectual property
- Multiple convertible note conversions
- Issued performance rights as part of share-based compensation
- No income tax expense due to deferred tax benefits
- Focus on capital management with no current share buy-back
- No material contingent liabilities reported
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Electro Optic Systems Holdings Limited (EOS) ORDINARY FULLY PAID |
Industrials |
$2,200 |
EOS LAND 156 Additional Information
|
29 Aug 2025 9:29AM |
$5.490 |
$10.150 |
risen by
84.88%
|
|
| EPX Limited (EPX) ORDINARY FULLY PAID |
Information Technology |
$15 |
2025 Appendix 4E and Annual Report
|
29 Aug 2025 9:29AM |
$0.029 |
$0.170 |
risen by
486.21%
|
|
EPX - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for 2025 was $15,272,563.
- Loss after income tax for 2025 was $5,750,642.
- Significant revenue contributions from the UK and Middle East segments.
- Focus on risk management and financial instruments.
- Contract assets include accrued revenue and incremental contract costs.
- Employee benefits and share-based compensation were highlighted.
- Deferred tax assets and tax strategies are outlined.
- Management's strategic initiatives aim to enhance future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EPX Limited (EPX) ORDINARY FULLY PAID |
Information Technology |
$15 |
2025 Appendix 4E and Annual Report
|
29 Aug 2025 9:29AM |
$0.029 |
$0.170 |
risen by
486.21%
|
|
EPX - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported a financial loss of $5.75 million after income tax.
- Increased revenue to $15.27 million.
- Additions to right-of-use assets and shares issued for business combinations.
- Total liabilities exceeded assets, resulting in net assets of $523,077.
- Emphasized performance-linked remuneration and long-term incentive plans.
- Detailed employee benefits and share-based payment expenses.
- Included significant foreign currency translation impacts on income.
- Reported directors and key management personnel's remuneration details.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gale Pacific Limited (GAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$21 |
FY25 Appendix 4E Preliminary Final Report
|
29 Aug 2025 9:28AM |
$0.098 |
$0.075 |
fallen by
23.47%
|
|
GAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Gale Pacific Limited reported a decrease in revenues by 1.1% for the year ended 30 June 2025.
- The net loss for the period attributable to members was $5.184 million, down from a profit of $332,000 in the previous year.
- No dividends were declared or recommended for the year ending 30 June 2025.
- Basic and diluted loss per share for the year was 1.82 cents, compared to a loss of 0.12 cents in the previous year.
- Net tangible assets per security decreased to 26.43 cents from 28.11 cents.
- The report includes a statement of material uncertainty related to going concern.
- A significant drop in earnings per share and net tangible assets per security is highlighted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
